OSX and SingHealth partner on Global Centre of Excellence
Filed with ASX · · 6 pages · English
Summary by 6ix AI
Osteopore Ltd. has announced a partnership with SingHealth to establish its first Global Centre of Excellence for customised medical devices at the Singapore General Hospital Campus. This collaboration aims to co-develop and scale Osteopore's medical devices while enhancing patient outcomes through improved healthcare practices. Osteopore's CEO expressed enthusiasm for the partnership, highlighting its potential to improve patient quality of life and reduce healthcare costs.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Osteopore
- Osteopore successfully raises A$2.9m from Entitlement Offer
- Activities Update Qtr Ending March 2024 and Appendix 4C
- Response to ASX Price and Volume Query
- Trading Halt
- Pause in Trading
Later from Osteopore
- A$18.7m Osteopore, NDCS and A*STAR project hits milestones
- Osteopore strikes Exclusive Distribution with Zimmer Biomet
- Activities Update Qtr Ending June 2024 and Appendix 4C
- OSX and University of Chile complete bone implant studies
- Osteopore to raise A$20m via redeemable convertible note
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore